Detecting hidden sequence propensity for amyloid fibril formation

Protein Science

Volumn 13, Issue 8, 2004, Pages 2149-2160

  Yoon, Sukjoon ^a,b   Welsh, William J ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b ARQULE INC   (United States)

Author keywords

Amyloid fibril; H P, SCOP; Hidden strand propensity; Secondary structure; Tertiary contacts

Indexed keywords

ACETYLCHOLINESTERASE; ALPHA SYNUCLEIN; AMYLIN; AMYLOID; AMYLOID BETA PROTEIN; MYOGLOBIN; PEPTIDE FRAGMENT;

ALGORITHM; AMINO ACID SEQUENCE; AMYLOIDOSIS; ARTICLE; HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE;

ACETYLCHOLINESTERASE; ALGORITHMS; ALPHA-SYNUCLEIN; AMYLOID BETA-PROTEIN; COMPUTATIONAL BIOLOGY; HUMANS; NERVE TISSUE PROTEINS; PROTEIN STRUCTURE, SECONDARY; SEQUENCE HOMOLOGY, AMINO ACID; SYNUCLEINS;

EID: 3342963982     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.04790604     Document Type: Article

References (41)

1. Balbirnie, M., Grothe, R., and Eisenberg, D.S. 2001. An amyloid-forming peptide from the yeast prion Sup35 reveals a dehydrated β-sheet structure for amyloid. Proc. Natl. Acad. Sci. 98: 2375-2380.
2. 2-Microglobulin amyloidosis: Insights from conservation analysis and fibril modeling by protein docking techniques. J. Mol. Biol. 330: 159-174.
3. -. 2003b. Convervation and amyloid formation: A study of the gelsolin-like family. Proteins 51: 266-282.
4. Berezovsky, I.N. and Trifonov, E.N. 2001. Van der Waals locks: Loop-n-lock structure of globular proteins. J. Mol. Biol. 307: 1419-1426.
5. Bodles, A.M., Guthrie, D.J., Greeg, B., and Irvine, G.B. 2001. Identification of the region of non-Aβ component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity. J. Neurochem. 78: 334-395.
6. Brenner, S.E., Koehl, P., and Levitt, M. 2000. The ASTRAL compendium for protein structure and sequence analysis. Nucleic Acids Res. 28: 254-256.
7. Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C.M., and Stefani, M. 2002. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416: 507-511.
8. Chiti, F., Webster, P., Taddei, N., Clark, A., Stefani, M., Ramponi, G., and Dobson, C.M. 1999. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl. Acad. Sci. 96: 3590-3594.
9. Chiti, F., Stefani, M., Taddei, N., Ramponi, G., and Dobson, C.M. 2003. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 424: 805-808.
10. Citron, M. 2002. Alzheimer's disease: Treatments in discovery and development. Nat. Neurosci. 5: 1055-1057.
11. Cordes, M.H., Burton, R.E., Walsh, N.P., McKnight, C.J., and Sauer, R.T. 2000. An evolutionary bridge to a new protein fold. Nat. Struct. Biol. 7: 1129-1132.
12. Cottingham, M.G., Hollinshead, M.S., and Vaux, D.J. 2002. Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-β peptide. Biochemistry 41: 13539-13547.
13. Cottingham, M.G., Voskuil, J.L., and Vaux, D.J. 2003. The intact human acetylcholinesterase C-terminal oligomerization domain is α-helical in situ and in isolation, but a shorter fragment forms β-sheet-rich amyloid fibrils and protofibrillar oligomers. Biochemistry 42: 10863-10873.
14. Couzin, J. 2002. Harmless proteins twist into troublemakers. Science 296: 28-29.
15. El-Agnaf, O.M., Jakes, R., Currar, M.D., Middleton, D., Ingenito, R., Bianchi, E., Pesse, A., Neill, D., and Wallace, A. 1998. Aggregates from mutant and wild-type a-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β-sheet and amyloid-like filaments. FEBS Lett. 440: 71-75.
16. Fändrich, M., Fletcher, M.A., and Dobson, C.M. 2001. Amyloid fibrils from muscle myoglobin. Nature 410: 165-166.
17. Fändrich, M., Forge, V., Buder, K., Kittler, M., Dobson, C.M., and Diekmann, S. 2003. Myoglobin forms amyloid fibrils by association of unfolded polypeptide segments. Proc. Natl. Acad. Sci. 100: 15463-15468.
18. Findeis, M.A. 2002. Peptide inhibitors of β-amyloid aggregation. Curr. Top. Med. Chem. 2: 417-423.
19. Fischer, K.F. and Marqusee, S. 2000. A rapid test for identification of autonomous folding units in proteins. J. Mol. Biol. 302: 701-712.
20. Giasson, B.I., Murray, I.V., Trojanowski, J.Q., and Lee, V.M. 2001. A hydrophobic stretch of 12 amino acid residues in the middle of a-synuclein is essential for filament assembly. J. Biol. Chem. 276: 2380-2386.
21. Hoppener, J.W., Ahren, B., and Lips, C.J.M. 2000. Islet amyloid and type 2 diabetes mellitus. N. Engl. J. Med. 343: 411-419.
22. Jimenez, J.L., Guijarro, J.I., Orlova, E., Zurdo, J., Dobson, C.M., Sunde, M., and Saibil, H.R. 1999. Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. EMBO J. 18: 815-821.
23. Kabsch, W. and Sander, C. 1983. Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22: 2577-2637.
24. Kallberg, Y., Gustafsson, M., Persson, B., Thyberg, J., and Johansson, J. 2001. Prediction of amyloid fibril-forming proteins. J. Biol. Chem. 276: 12945-12950.
25. Mangione, P., Sunde, M., Giorgetti, S., Stoppini, M., Esposito, G., Gianelli, L., Obici, L., Asti, L., Andreola, A., Viglino, P., et al. 2001. Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure. Protein Sci. 10: 187-199.
26. Mazor, Y., Gilead, S., Benhar, I., and Gazit, E. 2002. Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide. J. Mol. Biol. 322: 1013-1024.
27. Minor Jr., D.L. and Kim, P.S. 1996. Context-dependent secondary structure formation of a designed protein sequence. Nature 380: 730-734.
28. Pan, X.-M., Niu, W.-D., and Wang, Z.-X. 1999. What is the minimum number of residues to determine the secondary structural state? J. Protein Chem. 18: 579-584.
29. Paz, M. and Serrano, L. 2004. Sequence determinants of amyloid fibril formation. Proc. Natl. Acad. Sci. 101: 87-92.
30. Permanne, B., Adessi, C., Saborio, G.P., Fraga, S., Frossard, M.-J., Dorpe, J.V., Dewachter, I., Banks, W.A., Leuven, F.V., and Soto, C. 2002. Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a β-sheet breaker peptide. FASEB J. 8: 860-862.
31. Plaxco, K.W., Simons, K.T., and Baker, D. 1998. Contact order, transition state placement and the refolding rates of single domain proteins. J. Mol. Biol. 277: 985-994.
32. Rost, B. 1996. PHD: Predicting one-dimensional protein structure by profile-based neural networks. Methods Enzymol. 266: 525-539.
33. Sacchettini, J.C. and Kelly, J.W. 2002. Therapeutic strategies for human amyloid diseases. Nat. Rev. Drug Discovery 1: 267-275.
34. Schwartz, R.M. and Dayhoff, M.O. 1978. Matrices for detecting distant relationships. In Atlas of protein sequence and structure (ed. M.O. Dayhoff), pp. 353-358. National Biomedical Research Foundation, Washington, DC.
35. Soto, C., Sigurdsson, E.M., Morelli, L., Kumar, R.A., Castano, E.M., and Frangione, B. 1998. β-Sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy. Nat. Med. 4: 822-826.
36. Spillantini, M.G., Schmidt, M.L., Lee, V.M., Trojanowski, J.Q., Jakes, R., and Goedert, M. 1997. α-Synuclein in Lewy bodies. Nature 388: 839-840.
37. Spillantini, M.G., Crowther, R.A., Jakes, R., Hasegawa, M., and Goedert, M. 1998. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. 95: 6469-6473.
38. Tjernberg, L.O., Naslund, J., Lindqvist, F., Johansson, J., Karlstrom, A.R., Thyberg, J., Terenius, L., and Nordstedt, C. 1996. Arrest of β-amyloid fibril formation by a pentapeptide ligand. J. Biol. Chem. 271: 8545-8548.
39. Ueda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D.A., Kondo, J., Ihara, Y., and Saitoh, T. 1993. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. 90: 11282-11286.
40. Wolfe, M.S. 2002. Therapeutic strategies for Alzheimer's disease. Nat. Rev. Drug Discovery 1: 859-866.
41. Zhou, X., Alber, F.A., Folkers, G., Gonnet, G.H., and Chelvanayagam, G. 2000. An analysis of the helix-to-strand transition between peptides with identical sequence. Proteins 41: 248-256.